Published in J Clin Pathol on April 22, 2008
DNA methylation profiling identifies global methylation differences and markers of adrenocortical tumors. J Clin Endocrinol Metab (2012) 1.67
Review paper: origin and molecular pathology of adrenocortical neoplasms. Vet Pathol (2009) 0.96
GATA4 is a critical regulator of gonadectomy-induced adrenocortical tumorigenesis in mice. Endocrinology (2012) 0.83
Survival and prognostic factors for adrenocortical carcinoma: a single institution experience. BMC Urol (2015) 0.82
Diagnosis: Novel molecular signatures for adrenocortical carcinoma. Nat Rev Endocrinol (2009) 0.80
Copy number variations alter methylation and parallel IGF2 overexpression in adrenal tumors. Endocr Relat Cancer (2015) 0.77
Adrenal cortical neoplasms: a study of clinicopathological features related to epidermal growth factor receptor gene status. Diagn Pathol (2014) 0.76
Prevalence of adrenal incidentaloma in a contemporary computerized tomography series. J Endocrinol Invest (2006) 2.53
ERCC1 and RRM1 gene expressions but not EGFR are predictive of shorter survival in advanced non-small-cell lung cancer treated with cisplatin and gemcitabine. Ann Oncol (2006) 2.34
Retrieved endogenous biotin: a novel marker and a potential pitfall in diagnostic immunohistochemistry. Histopathology (1997) 2.31
Reassessing the current TNM lymph node staging for renal cell carcinoma. Eur Urol (2005) 2.30
Ghrelin, a natural GH secretagogue produced by the stomach, induces hyperglycemia and reduces insulin secretion in humans. J Clin Endocrinol Metab (2001) 2.13
Restoration of fertility by in-vitro spermatogenesis. Lancet (1999) 2.10
In-vitro maturation of immature human male germ cells. Mol Cell Endocrinol (2000) 2.04
Expression of the neuroendocrine phenotype in carcinomas of the breast. Semin Diagn Pathol (2000) 1.94
Regulation of Axl receptor tyrosine kinase expression by miR-34a and miR-199a/b in solid cancer. Oncogene (2011) 1.75
Localization of a susceptibility gene for familial nonmedullary thyroid carcinoma to chromosome 2q21. Am J Hum Genet (2001) 1.68
The probability of abnormal preimplantation development can be predicted by a single static observation on pronuclear stage morphology. Hum Reprod (1999) 1.59
Application of an immunodiagnostic method for improving preoperative diagnosis of nodular thyroid lesions. Lancet (2001) 1.54
Intravenous immunoglobulin therapy in pregnant patients affected with systemic lupus erythematosus and recurrent spontaneous abortion. Rheumatology (Oxford) (2008) 1.54
Sorafenib may induce hypophosphatemia through a fibroblast growth factor-23 (FGF23)-independent mechanism. Ann Oncol (2011) 1.48
Apocrine carcinoma of the skin. A clinicopathologic, immunocytochemical, and ultrastructural study. Cancer (1993) 1.48
Low dose prednisolone administration in routine ICSI patients does not improve pregnancy and implantation rates. Hum Reprod (2002) 1.47
Cardiac screening by STIC: can sonologists performing the 20-week anomaly scan pick up outflow tract abnormalities by scrolling the A-plane of STIC volumes? Ultrasound Obstet Gynecol (2008) 1.44
Preliminary evidence that Ghrelin, the natural GH secretagogue (GHS)-receptor ligand, strongly stimulates GH secretion in humans. J Endocrinol Invest (2000) 1.44
Gastric carcinoids and their precursor lesions. A histologic and immunohistochemical study of 23 cases. Cancer (1991) 1.42
Expression of apocrine differentiation markers in neuroendocrine breast carcinomas of aged women. Mod Pathol (2001) 1.41
Non-acylated ghrelin counteracts the metabolic but not the neuroendocrine response to acylated ghrelin in humans. J Clin Endocrinol Metab (2004) 1.40
Acromegaly due to ectopic secretion of GHRH by bronchial carcinoid in a patient with empty sella. J Endocrinol Invest (2003) 1.40
Heparin-induced thrombocytopenia in the presence of a heparin-bonded bypass graft. Vascular (2011) 1.38
Identification, characterization, and biological activity of specific receptors for natural (ghrelin) and synthetic growth hormone secretagogues and analogs in human breast carcinomas and cell lines. J Clin Endocrinol Metab (2001) 1.37
β1 integrin controls EGFR signaling and tumorigenic properties of lung cancer cells. Oncogene (2011) 1.34
Endocrine activities of ghrelin, a natural growth hormone secretagogue (GHS), in humans: comparison and interactions with hexarelin, a nonnatural peptidyl GHS, and GH-releasing hormone. J Clin Endocrinol Metab (2001) 1.32
Secondary and tertiary hyperparathyroidism: causes of recurrent disease after 446 parathyroidectomies. Ann Surg (2001) 1.27
Helicobacter pylori virulence genes and host IL-1RN and IL-1beta genes interplay in favouring the development of peptic ulcer and intestinal metaplasia. Cytokine (2002) 1.20
p53 but not bcl-2 immunostaining is predictive of poor clinical complete response to primary chemotherapy in breast cancer patients. Clin Cancer Res (2000) 1.16
Accuracy of mammography and echography versus clinical palpation in the assessment of response to primary chemotherapy in breast cancer patients with operable disease. Breast Cancer Res Treat (2001) 1.16
Clinical significance of neuroendocrine carcinoma of the breast. Ann Oncol (2001) 1.16
Preincubation of human oocytes may improve fertilization and embryo quality after intracytoplasmic sperm injection. Hum Reprod (1998) 1.15
Characterization of thyroid 'follicular neoplasms' in fine-needle aspiration cytological specimens using a panel of immunohistochemical markers: a proposal for clinical application. Endocr Relat Cancer (2005) 1.14
Analysis of Helicobacter pylori vacA and cagA genotypes and serum antibody profile in benign and malignant gastroduodenal diseases. Gut (1998) 1.14
Polscope analysis of meiotic spindle changes in living metaphase II human oocytes during the freezing and thawing procedures. Hum Reprod (2004) 1.13
Mixed medullary-follicular thyroid carcinoma. Molecular evidence for a dual origin of tumor components. Am J Pathol (1999) 1.10
Thyroid transcription factor 1 and cytokeratins 1, 5, 10, 14 (34betaE12) expression in basaloid and large-cell neuroendocrine carcinomas of the lung. Hum Pathol (2001) 1.09
Management of poor responders in IVF. Reprod Biomed Online (2005) 1.09
Relationship between chronic tadalafil administration and improvement of endothelial function in men with erectile dysfunction: a pilot study. Int J Impot Res (2006) 1.09
Relationship between meiotic spindle location with regard to the polar body position and oocyte developmental potential after ICSI. Hum Reprod (2003) 1.08
Visceral pain threshold is deeply lowered far from the head in migraine. Headache (1994) 1.06
Low-dose monitored mitotane treatment achieves the therapeutic range with manageable side effects in patients with adrenocortical cancer. J Clin Endocrinol Metab (2000) 1.05
Neuroendocrine bronchial and thymic tumors: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol (2012) 1.04
Cytological classification of thyroid nodules. Proposal of the SIAPEC-IAP Italian Consensus Working Group. Pathologica (2010) 1.04
Ghrelin: more than a natural GH secretagogue and/or an orexigenic factor. Clin Endocrinol (Oxf) (2005) 1.04
Relationship between tumour shrinkage and reduction in Ki67 expression after primary chemotherapy in human breast cancer. Br J Cancer (2001) 1.04
Detection and molecular characterisation of thyroid cancer precursor lesions in a specific subset of Hashimoto's thyroiditis. Br J Cancer (2004) 1.02
Prognostic significance of disordered calcium metabolism in hormone-refractory prostate cancer patients with metastatic bone disease. Prostate Cancer Prostatic Dis (2008) 1.02
Reproductive capacity of spermatozoa from men with testicular failure. Hum Reprod (1999) 1.00
Mitotane levels predict the outcome of patients with adrenocortical carcinoma treated adjuvantly following radical resection. Eur J Endocrinol (2013) 1.00
Binding of antibodies against human prealbumin to intestinal and bronchial carcinoids and to pancreatic endocrine tumours. Virchows Arch B Cell Pathol Incl Mol Pathol (1984) 0.99
Somatostatin receptor tissue distribution in lung neuroendocrine tumours: a clinicopathologic and immunohistochemical study of 218 'clinically aggressive' cases. Ann Oncol (2009) 0.97
Uric acid is not an independent predictor of cardiovascular mortality in type 2 diabetes: a population-based study. Atherosclerosis (2011) 0.97
"Mold-like" calcification of the left atrium and of the pulmonary veins. Total endoatriectomy in a patient undergoing mitral valve replacement. Eur J Cardiothorac Surg (1994) 0.96
Hopes and facts about mild ovarian stimulation. Reprod Biomed Online (2007) 0.96
Grading the neuroendocrine tumors of the lung: an evidence-based proposal. Endocr Relat Cancer (2013) 0.96
The neuroendocrine phenotype in prostate cancer: basic and clinical aspects. J Endocrinol Invest (2005) 0.95
Evidence of overadditive interaction between fenoterol and ipratropium bromide in the counteraction of cholinomimetic-induced tracheobronchial contractions. Arzneimittelforschung (1981) 0.95
Circulating chromogranin A in the assessment of patients with neuroendocrine tumours. A single institution experience. Ann Oncol (2001) 0.95
Relationship between CA 15-3 serum levels and disease extent in predicting overall survival of breast cancer patients with newly diagnosed metastatic disease. Br J Cancer (1997) 0.94
Chemotherapy with dacarbazine and 5-fluorouracil in advanced medullary thyroid cancer. Ann Oncol (1994) 0.94
Cortistatin, but not somatostatin, binds to growth hormone secretagogue (GHS) receptors of human pituitary gland. J Endocrinol Invest (2001) 0.93
Pretreatment haemoglobin levels significantly predict the tumour response to primary chemotherapy in human breast cancer. Br J Cancer (2003) 0.93
Prevention of Mediterranean anaemia in Latium, Italy, today. J Med Genet (1994) 0.93
Increased pathological complete response rate after a long-term neoadjuvant letrozole treatment in postmenopausal oestrogen and/or progesterone receptor-positive breast cancer. Br J Cancer (2013) 0.93
Binding of 125I-labeled ghrelin to membranes from human hypothalamus and pituitary gland. J Endocrinol Invest (2001) 0.93
Galectin-3: presurgical marker of thyroid follicular epithelial cell-derived carcinomas. J Endocrinol Invest (2004) 0.92
Pulmonary giant cell carcinoma: pathological entity or morphological phenotype? Histopathology (1998) 0.92
Effect of neoadjuvant chemotherapy on Ki67 labelling index, c-erbB-2 expression and steroid hormone receptor status in human breast tumours. Anticancer Res (1996) 0.92
Multidimensional geriatric assessment in treatment decision in elderly cancer patients: 6-year experience in an outpatient geriatric oncology service. Crit Rev Oncol Hematol (2008) 0.92
Complement system and rheumatoid arthritis: relationships with autoantibodies, serological, clinical features, and anti-TNF treatment. Int J Immunopathol Pharmacol (2011) 0.92
Multimodal management of stages III-IVa malignant thymoma. Lung Cancer (2004) 0.91
Specific haplotypes of the RET proto-oncogene are over-represented in patients with sporadic papillary thyroid carcinoma. J Med Genet (2002) 0.91
Cumulative pregnancy rates after transfer of fresh and thawed embryos. Eur J Obstet Gynecol Reprod Biol (2004) 0.91
Immunohistochemical analysis of benign and malignant papillary lesions of the breast. Am J Surg Pathol (1983) 0.91
Cytologic features of poorly differentiated 'insular' carcinoma of the thyroid, as revealed by fine-needle aspiration biopsy. Am J Clin Pathol (1990) 0.90
The activity (calcium oscillator?) responsible for human oocyte activation after injection with round spermatids is associated with spermatid nuclei. Fertil Steril (2000) 0.90
Serum antibodies anti-H. pylori and anti-CagA: a comparison between four different assays. J Clin Lab Anal (1999) 0.90
Criteria predicting the absence of spermatozoa in the Sertoli cell-only syndrome can be used to improve success rates of sperm retrieval. Hum Reprod (2000) 0.89
Biologic activities of growth hormone secretagogues in humans. Endocrine (2001) 0.88
Body composition and energy metabolism of moulting eudyptid penguins. Comp Biochem Physiol A Comp Physiol (1977) 0.88
Germ cell apoptosis in men with complete and incomplete spermiogenesis failure. Mol Hum Reprod (1998) 0.88
Lonidamine significantly increases the activity of epirubicin in patients with advanced breast cancer: results from a multicenter prospective randomized trial. J Clin Oncol (1996) 0.88
Management of adrenal cancer: a 2013 update. J Endocrinol Invest (2014) 0.87
Hexarelin protects H9c2 cardiomyocytes from doxorubicin-induced cell death. Endocrine (2001) 0.87
Specific binding sites for synthetic growth hormone secretagogues in non-tumoral and neoplastic human thyroid tissue. J Endocrinol (2000) 0.87
Gemcitabine plus cisplatin in the treatment of patients with advanced non-small cell lung cancer: a phase II study. Anticancer Res (2003) 0.87
Weekly cisplatin plus capecitabine in metastatic breast cancer patients heavily pretreated with both anthracycline and taxanes. Oncology (2005) 0.87
Laser-assisted intracytoplasmic sperm injection. Fertil Steril (2001) 0.87
Relationship between neuroendocrine features and prognostic parameters in human prostate adenocarcinoma. Ann Oncol (2001) 0.86
Proliferative activity in parathyroid tumors as detected by Ki-67 immunostaining. Hum Pathol (1995) 0.86
Immunohistochemical markers of sweat gland tumors. J Cutan Pathol (1986) 0.86
Association of breast carcinoma and multiple intraductal papillomas: an histological and immunohistochemical investigation. Histopathology (1984) 0.86
Specific receptors for synthetic GH secretagogues in the human brain and pituitary gland. J Endocrinol (1998) 0.86
Independent factors predict supranormal CA 15-3 serum levels in advanced breast cancer patients at first disease relapse. Tumour Biol (2002) 0.86
Spermatids as gametes: indications and limitations. Hum Reprod (1998) 0.85
Management of adjuvant mitotane therapy following resection of adrenal cancer. Endocrine (2012) 0.85
Chromogranin A and B and secretogranin II in bronchial and intestinal carcinoids. Virchows Arch A Pathol Anat Histopathol (1987) 0.85